NEWS DETAIL

Opinion/Decision Regarding the Pediatric Research Program (PIP): Jyseleca, Figoratinib Maleate, Decision Type: PM: Decision Regarding Amendments to an Agreed-Upon PIP Application, Therapeutic Area: Musculoskeletal and Connective Tissue Diseases, PIP Number: EMA/PE/0000232302

Alfasigma S.p.A.

Medical Information July 2, 2026

Full Article Content

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Products Mentioned in This Article

These products were automatically matched from the article title, summary, and full content.

Frequently Asked Questions

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Buy Online.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.